Pathogenesis, clinical picture and treatment of von Willebrand's disease.
Von Willebrand's disease is probably the most common congenital bleeding disorder, with a prevalence close to 1% in some epidemiological studies. The disease is caused by a quantitative deficiency or a qualitative defect of the von Willebrand factor, which is a multimeric glycoprotein consisting of subunits of 2050 amino acids. The size of multimers ranges from approximately 500 kDa to 20 MDa. Each subunit consist of repeated domain structures. Several functional domains have been identified which can bind such structures as platelet receptors glycoprotein Ib or IIb/IIIA, heparin, collagen or factor VIII. The von Willebrand factor has two main functions in haemostasis, to promote normal platelet adhesion and to be a carrier protein for factor VIII. Von Willebrand's disease is divided into three major types and several subtypes depending on the quantity and quality of the von Willebrand factor in plasma and platelets. A new classification has recently been proposed. Typical symptoms are mucosal bleeding, easy bruising and increased bleeding tendency in connection with tooth extractions and other invasive procedures. Severe cases may have joint bleeding and other haemophilia-like bleeding. Desmopressin is the treatment of choice in mild cases, whereas more severe cases need treatment with factor VIII concentrates.
Lethagen
S R
SR
Department for Coagulation Disorders, University of Lund, Malmö, Sweden.
D003894:Deamino Arginine Vasopressin / Q000494:pharmacology / Q000627:therapeutic use; D005169:Factor VIII / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006487:Hemostasis / Q000502:physiology; D006801:Humans; D008297:Male; D012076:Renal Agents / Q000494:pharmacology / Q000627:therapeutic use; D014842:von Willebrand Diseases / Q000145:classification / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D014841:von Willebrand Factor / Q000096:biosynthesis / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use
D012076:Renal Agents; D014841:von Willebrand Factor; D005169:Factor VIII; D003894:Deamino Arginine Vasopressin